Angiotensin Inhibition, TGF-β and EMT in Cancer

SIMPLE SUMMARY: Angiotensin inhibitors are broadly applied in the treatment of renal and cardiovascular diseases. This review aims to show that these drugs have also been beneficial in cancer therapies. Underlying molecular mechanisms are elucidated. Angiotensin signaling and the antifibrotic proper...

Descripción completa

Detalles Bibliográficos
Autores principales: Pallasch, Fabian Bernhard, Schumacher, Udo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601465/
https://www.ncbi.nlm.nih.gov/pubmed/32998363
http://dx.doi.org/10.3390/cancers12102785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601465/
https://www.ncbi.nlm.nih.gov/pubmed/32998363
http://dx.doi.org/10.3390/cancers12102785

Ejemplares similares